Development of a preclinical model of myeloid tumors with high immune checkpoints expression

Development of a preclinical model of myeloid tumors with high immune checkpoints expression

Background. Myelodysplastic syndrome is a group of malignant blood diseases with a high risk of transformation into acute myeloid leukemia. One treatment approach is to target immune checkpoints (ICs) that are overexpressed on tumor cells. To develop these drugs, relevant models are needed for hight...

Full description

Saved in:
Bibliographic Details
Main Authors: D. A. Senichkina, A. I. Shakirova, O. S. Epifanovskaya, I. N. Gaponenko, T. A. Pyatiizbyantsev, E. V. Belotserkovskaya, A. B. Malyshecheva, K. V. Lepik, I. S. Moiseev
Format: Article
Language:Russian
Published: ABV-press 2024-12-01
Series:Онкогематология
Subjects:
tim3
l1
th1
kg1
monomac1
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/981
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/981

Similar Items